{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:35:24Z","timestamp":1791070524199,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"23-24","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.lfs.2010.04.008","type":"journal-article","created":{"date-parts":[[2010,4,26]],"date-time":"2010-04-26T08:37:45Z","timestamp":1272271065000},"page":"899-905","source":"Crossref","is-referenced-by-count":52,"title":["In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein"],"prefix":"10.1016","volume":"86","author":[{"given":"Chunbo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"48","key":"10.1016\/j.lfs.2010.04.008_bib1","doi-asserted-by":"crossref","first-page":"32167","DOI":"10.1074\/jbc.273.48.32167","article-title":"Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain","volume":"273","author":"Bakos","year":"1998","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.lfs.2010.04.008_bib2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuropharm.2006.07.038","article-title":"Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein","volume":"52","author":"Baltes","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2010.04.008_bib3","series-title":"Fast facts: epilepsy","first-page":"56","author":"Brodie","year":"2005"},{"issue":"1","key":"10.1016\/j.lfs.2010.04.008_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0928-0987(00)00141-X","article-title":"Analysis of drug transport and metabolism in cell monolayer systems that have been modified by cytochrome P4503A4 cDNA-expression","volume":"12","author":"Crespi","year":"2000","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"5","key":"10.1016\/j.lfs.2010.04.008_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/10611860600720814","article-title":"Limited P-glycoprotein mediated efflux for anti-epileptic drugs","volume":"14","author":"Crowe","year":"2006","journal-title":"Journal of Drug Targeting"},{"issue":"9","key":"10.1016\/j.lfs.2010.04.008_bib6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMoa0902014","article-title":"Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy","volume":"362","author":"Glauser","year":"2010","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.lfs.2010.04.008_bib7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1527-3458.2007.00009.x","article-title":"Ethosuximide: from bench to bedside","volume":"13","author":"G\u00f6ren","year":"2007","journal-title":"CNS Drug Reviews"},{"issue":"25","key":"10.1016\/j.lfs.2010.04.008_bib8","doi-asserted-by":"crossref","first-page":"12163","DOI":"10.1016\/S0021-9258(18)37730-5","article-title":"The multidrug transporter, a double-edged sword","volume":"263","author":"Gottesman","year":"1988","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.lfs.2010.04.008_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.taap.2008.02.026","article-title":"In vitro and in vivo evaluation of the effects of piperine on P-gp function and expression","volume":"230","author":"Han","year":"2008","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"1","key":"10.1016\/j.lfs.2010.04.008_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2006.10.007","article-title":"A primer on the mechanics of P-glycoprotein the multidrug transporter","volume":"55","author":"Hennessy","year":"2007","journal-title":"Pharmacological Research"},{"issue":"5","key":"10.1016\/j.lfs.2010.04.008_bib11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/FPC.0b013e3282f85e36","article-title":"Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs","volume":"18","author":"Hung","year":"2008","journal-title":"Pharmacogenetics and Genomics"},{"issue":"1","key":"10.1016\/j.lfs.2010.04.008_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochimica et Biophysica Acta"},{"issue":"5811","key":"10.1016\/j.lfs.2010.04.008_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.1135308","article-title":"A \u201csilent\u201d polymorphism in the MDR1 gene changes substrate specificity","volume":"315","author":"Kimchi-Sarfaty","year":"2007","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.lfs.2010.04.008_bib14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.lfs.2010.04.008_bib15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.0013-9580.2005.31904.x","article-title":"Potential role of drug transporters in the pathogenesis of medically intractable epilepsy","volume":"46","author":"Kwan","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.lfs.2010.04.008_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(02)01453-2","article-title":"Differential expression of multidrug resistance genes in na\u00efve rat brain","volume":"339","author":"Kwan","year":"2003","journal-title":"Neuroscience Letters"},{"issue":"8","key":"10.1016\/j.lfs.2010.04.008_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"Loscher","year":"2005","journal-title":"Nature Reviews"},{"issue":"6","key":"10.1016\/j.lfs.2010.04.008_bib18","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.neuropharm.2008.08.032","article-title":"Several major antiepileptic drugs are substrates for human P-glycoprotein","volume":"46","author":"Luna-Tortos","year":"2008","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.lfs.2010.04.008_bib19","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1007\/s11095-009-9961-8","article-title":"The antiepileptic drug topiramate is a substrate for human P-glycoprotein but not multidrug resistance proteins","volume":"26","author":"Luna-Tortos","year":"2009","journal-title":"Pharmaceutical Research"},{"issue":"2","key":"10.1016\/j.lfs.2010.04.008_bib20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-3565(24)39245-6","article-title":"Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein","volume":"293","author":"Pauli-Magnus","year":"2000","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"10","key":"10.1016\/j.lfs.2010.04.008_bib21","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1046\/j.1528-1157.2001.01901.x","article-title":"In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood\u2013brain barrier of rats","volume":"42","author":"Potschka","year":"2001","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.lfs.2010.04.008_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(02)00423-8","article-title":"P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood\u2013brain barrier: evidence from microdialysis experiments in rats","volume":"327","author":"Potschka","year":"2002","journal-title":"Neuroscience Letters"},{"issue":"2\u20133","key":"10.1016\/j.lfs.2010.04.008_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0920-1211(98)00106-5","article-title":"Clinical aspects and biological bases of drug-resistant epilepsies","volume":"34","author":"Regesta","year":"1999","journal-title":"Epilepsy Research"},{"issue":"1\u20133","key":"10.1016\/j.lfs.2010.04.008_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2008.09.014","article-title":"Exploring the possible interaction between anti-epilepsy drugs and multidrug efflux pumps; in vitro observations","volume":"598","author":"Rivers","year":"2008","journal-title":"European Journal of Pharmacology"},{"issue":"14","key":"10.1016\/j.lfs.2010.04.008_bib25","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1523\/JNEUROSCI.22-14-05833.2002","article-title":"Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance","volume":"22","author":"Rizzi","year":"2002","journal-title":"Journal of Neuroscience"},{"issue":"3","key":"10.1016\/j.lfs.2010.04.008_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/scbi.1997.0068","article-title":"The physiological function of drug-transporting P-glycoproteins","volume":"8","author":"Schinkel","year":"1997","journal-title":"Seminars in Cancer Biology"},{"issue":"11","key":"10.1016\/j.lfs.2010.04.008_bib27","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI118699","article-title":"P-glycoprotein in the blood\u2013brain barrier of mice influences the brain penetration and pharmacological activity of many drugs","volume":"97","author":"Schinkel","year":"1996","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/j.lfs.2010.04.008_bib28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1525-5050(02)00511-5","article-title":"P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice","volume":"3","author":"Sills","year":"2002","journal-title":"Epilepsy & Behavior"},{"issue":"1","key":"10.1016\/j.lfs.2010.04.008_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/mp800122b","article-title":"Biopharmaceutics classification system: validation and learnings of an in vitro permeability assay","volume":"6","author":"Thiel-Demby","year":"2009","journal-title":"Molecular Pharmaceutics"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2010.04.008_bib30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2007.12.024","article-title":"Application and limitation of inhibitors in drug-transporter interactions studies","volume":"356","author":"Wang","year":"2008","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"10.1016\/j.lfs.2010.04.008_bib31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1124\/jpet.103.054197","article-title":"Interaction of antiepileptic drugs with human P-glycoprotein in vitro","volume":"307","author":"Weiss","year":"2003","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"10","key":"10.1016\/j.lfs.2010.04.008_bib32","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2460\/ajvr.68.10.1106","article-title":"Assessment of antiepileptic drugs as substrates for canine P-glycoprotein","volume":"68","author":"West","year":"2007","journal-title":"American Journal of Veterinary Research"},{"issue":"3\u20134","key":"10.1016\/j.lfs.2010.04.008_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejps.2007.04.001","article-title":"Mechanistic study on the intestinal absorption and disposition of baicalein","volume":"31","author":"Zhang","year":"2007","journal-title":"European Journal of Pharmaceutical Sciences"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320510001797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320510001797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:32:39Z","timestamp":1740029559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320510001797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":33,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0024320510001797"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2010.04.008","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}